Hui Zhu

Hui Zhu

Auto-generated profile, based on publicly available information

Hui Zhu

State Key Laboratory for Manufacturing Systems Engineering, Xi'an Jiaotong University, Xi'an 710049, P. R. China; National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Additive Manufacturing Medical Devices, Xi'an Jiaotong University, Xi'an 710049, P. R. China; State Industry-Education Integration Center for Medical Innovations, Xi'an Jiaotong University, Xi'an 710049, P. R. China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Acta Biomaterialia
Verified
Journal Article
Open access
HZHui Zhu
Hui Zhu
Kai ZhengKai Zheng
Kai Zheng
Aldo R. BoccacciniAldo R. Boccaccini
Aldo R. Boccaccini
Mesoporous silica-based materials, especially mesoporous bioactive glasses (MBGs), are being highly considered for biomedical applications, including drug delivery and tissue engineering, not only because of their bioactivity and biocompatibility but also due to their tunable composition and potential use as drug delivery carriers owing to their controllable nanoporous structure. Numerous researches have reported that MBGs can be doped with various therapeutic ions (strontium, copper, magnesium, zinc, lithium, silver, etc.) and loaded with specific biomolecules (e.g., therapeutic drugs, antibiotics, growth factors) achieving controllable loading and release kinetics. Therefore, co-delivery of ions and biomolecules using a single MBG carrier is highly interesting as this approach provides synergistic effects toward improved therapeutic outcomes in comparison to the strategy of sole drug or ion delivery. In this review, we discuss the state-of-the-art in the field of mesoporous silica-based materials used for co-delivery of ions and therapeutic drugs with osteogenesis/cementogenesis, angiogenesis, antibacterial and anticancer properties. The analysis of the literature reveals that specially designed mesoporous nanocarriers can release multiple ions and drugs at therapeutically safe and relevant levels, achieving the desired biological effects (in vivo, in vitro) for specific biomedical applications. It is expected that this review on the ion/drug co-delivery concept using MBG carriers will shed light on the advantages of such co-delivery systems for clinical use. Areas for future research directions are identified and discussed.

24 December 2022 in Bio-Design and Manufacturing
Verified
Journal Article
Closed access
PDF file
ZQZhennan Qiu
Zhennan Qiu
HZHui Zhu
Hui Zhu
YWYutao Wang
Yutao Wang
AKAyiguli Kasimu
Ayiguli Kasimu
DLDichen Li
Dichen Li
Jiankang HeJiankang He
Jiankang He

7 June 2025 in Acta Biomaterialia
Verified
Journal Article
Closed access
HZHui Zhu
Hui Zhu
CYCong Yao
Cong Yao
ZXZhengqi Xu
Zhengqi Xu
GSGuojin Shang
Guojin Shang
JPJianhua Peng
Jianhua Peng
ABAldo R. Boccaccini
Aldo R. Boccaccini

3 July 2025 in Materials Letters
Verified
Journal Article
Closed access
HZHui Zhu
Hui Zhu
XHXinxin Huang
Xinxin Huang
XHXiaxuan Hui
Xiaxuan Hui
HXHuangfan Xie
Huangfan Xie
JPJianhua Peng
Jianhua Peng
ABAldo R. Boccaccini
Aldo R. Boccaccini